JAZZ:NASDAQ
Jazz Pharmaceuticals PLC
US$218.42
arrow_downward
-1.81%(-4.03) 1D
US$218.42
0.00% (0.00)
bedtimeවේලාවෙන් පසු
වසා ඇත: වප් 9, 16.00.01 ග්‍රිමවේ-4 · USD
search
සියලු සංකේත
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
insights_autoJAZZ සඳහා ඉහළම ඇතුළාන්තයන් උත්පාදනය කරමින්...
විවෘත කරන්න
US$221.79
ඉහළ
US$227.00
පහළ
US$213.20
වෙ.පො ප්‍රාග්ධනය
බි14.18
දළ පරිමාව
ද935.53
හඬ පරිමාණය
මි1.29
P/E අනුපාතය
14.93
සති-52 ඉහළ
US$266.38
සති-52 පහළ
US$128.80
EPS
US$14.63
බීටා
0.37
ගෙවිය යුතු කොටස්
මි64.92
සේවකයින් ගණන
ද3
විවෘත කරන්න
US$221.79
ඉහළ
US$227.00
පහළ
US$213.20
වෙ.පො ප්‍රාග්ධනය
බි14.18
දළ පරිමාව
ද935.53
හඬ පරිමාණය
මි1.29
P/E අනුපාතය
14.93
සති-52 ඉහළ
US$266.38
සති-52 පහළ
US$128.80
EPS
US$14.63
බීටා
0.37
ගෙවිය යුතු කොටස්
මි64.92
සේවකයින් ගණන
ද3
පුවත් සහ කථා
වෙබ් මූලාශ්‍ර සහ ප්‍රවෘත්ති හවුල්කරුවන්ගෙන්
Traders Union
·
පැය 15කට පෙර
Jazz Pharmaceuticals gets Cramer backing in CNBC stock call segment
TipRanks
·
දින 1කට පෙර
Jazz Pharmaceuticals Plans Commercial Leadership Transition Ahead
Investing.com South Africa
·
දින 1කට පෙර
Form 4 Jazz Pharmaceuticals plc For: 7 October By Investing.com
ChartMill
·
දින 1කට පෙර
Jazz Pharmaceuticals (NASDAQ:JAZZ): An Undervalued Biopharma Value Stock
පැතිකඩ
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid. In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness in narcolepsy as well as obstructive sleep apnea. In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America. Wikipedia
Jazz Pharmaceuticals PLC ගැන